|
Tector, A. J., Adams, A. B., Tector, M. (2023). Current Status of Renal Xenotransplantation and Next Steps. Kidney360, 4(2), 278-284. PMID: 36821619 doi: 10.34067/KID.0007152021
|
|
Badell, I. R., Bray, R. A., Elbein, R., Chami, A. S., Easley, K. A., Pastan, S. O., Guasch, A., Gebel, H. M., Adams, A. B., Larsen, C. P. (2021). Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial. Transplantation, 105(12), e395-e396. PMID: 34818307 doi: 10.1097/TP.0000000000003852
|
|
Adams, A. B., Lovasik, B. P., Faber, D. A., Burlak, C., Breeden, C., Estrada, J. L., Reyes, L. M., Vianna, R. M., Tector, M. F., Tector, A. J. (2021). Anti-C5 Antibody Tesidolumab Reduces Early Antibody-mediated Rejection and Prolongs Survival in Renal Xenotransplantation. Annals of surgery, 274(3), 473-480. PMID: 34238812 doi: 10.1097/SLA.0000000000004996
|
|
Kirk, A. D., Adams, A. B., Durrbach, A., Ford, M. L., Hildeman, D. A., Larsen, C. P., Vincenti, F., Wojciechowski, D., Woodle, E. S. (2021). Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 21(5), 1691-1698. PMID: 33128812 doi: 10.1111/ajt.16386
|
|
Thapa, M., Tedesco, D., Gumber, S., Elrod, E. J., Han, J. H., Kitchens, W. H., Magliocca, J. F., Adams, A. B., Grakoui, A. (2020). Blockade of BAFF Reshapes the Hepatic B Cell Receptor Repertoire and Attenuates Autoantibody Production in Cholestatic Liver Disease. Journal of immunology (Baltimore, Md. : 1950), 204(12), 3117-3128. PMID: 32332110 PMCID: PMC7306885 doi: 10.4049/jimmunol.1900391
|